Robotic primary retroperitoneal lymph node dissection (R-RPLND) may offer lower morbidity and improved perioperative outcomes than open RPLND (O-RPLND) for patients with clinical stage 2 (CS II) testicular cancer, according to new research presented at the 24th Annual Meeting of the Society of Urologic Oncology. O-RPLND is considered by many to be the gold standard for primary dissection of the retroperitoneal lymph nodes, though an increased utilization of R-RPLND has been observed in recent years because of its potential for lower blood loss, shorter hospital length of stay (LOS), faster recovery, and superior cosmetic results. A comparison of ...
Testicular, Penile, and Rare Malignancies
Advertisement
Latest News
From presentation with a testicular mass to treatment options, this provides valuable insights for community oncologists.
Dr. Wagner details his study on finding novel prognostic factors for relapse in patients with stage I testicular seminoma.
Drs. Bagrodia and Ambinder provide an overview of the care continuum for newly diagnosed testicular cancer patients.
Drs. Bagrodia and Ambinder walk through a community urologist's approach to a patient who presents with a testicular mass.
Patients with a complete resection at pcRPLND and <10% viable cells had favorable outcomes without any further treatment.
AUA Amendment to Testicular Cancer Guideline Includes New Treatment Options, Imaging Recommendations
The AUA released a new amendment to their 2019 guideline for the diagnosis and treatment of early-stage testicular cancer.Advertisement
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Conference Coverage
The retrospective analysis evaluated the data of patients who underwent multiagent chemotherapy.
At SUO 2023, Dr. Nicholas Corsi, UT Southwestern, presented one of the largest multinational studies on NAC in UTUC to date.
Almost half of all patients initiating 1L platinum-based chemotherapy were unable to receive maintenance avelumab treatment.
The generative AI model ChatGPT was fed a prostate cancer risk stratification algorithm.
The primary outcome was the potential for focal or hemi-gland ablation following analysis of the final pathologic specimen.
An analysis compared the outcomes of patients with mRCC who underwent cytoreductive nephrectomy and first-line TKI or IO.
Advertisement
Advertisement
Trending
The first PET scans using Illuccix, Telix’s PSMA-PET imaging agent, have been carried out in cooperation with BAMF Health.
Few biomarkers predict therapeutic response to radiation or adjunctive treatments in PCa patients treated with radiotherapy.
Metabolites were shown to have “the highest potential for differences between urine levels in healthy and BC patients."
